List | Section | Observation |
---|---|---|
El Salvador - 2019 | SUEROS INMUNES E INMUNOGLOBULINAS | No observations |
List | Section | Observation |
---|---|---|
El Salvador - 2019 | SUEROS INMUNES E INMUNOGLOBULINAS | No observations |
List | Section | Observation |
---|---|---|
Suriname. NGK-C-011 | 29.2 Other Special Essential Medicines | No observations |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 07. ENFERMEDADES INMUNOALERGICAS | No observations |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 07. ENFERMEDADES INMUNOALERGICAS | No observations |
List | Section | Observation |
---|---|---|
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: BBO. |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 07. ENFERMEDADES INMUNOALERGICAS | No observations |
List | Section | Observation |
---|---|---|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 80:04 Serums/Antitoxins | No observations |
List | Section | Observation |
---|---|---|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 80:04 Serums/Antitoxins | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.1. Human immunoglobulins |
Others observations: Indicated for primary immune deficiency. |
PAHO Strategic Fund Medicine List | 4.1. Plasma fractions for specific use |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.1. Human immunoglobulins |
Others observations: Indicated for primary immune deficiency and Kawasaki disease. |
PAHO Strategic Fund Medicine List | 4.1. Plasma fractions for specific use |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: INTACGLOBIN (INMUN. HUMANA G) FCO. X 50 ML (2,5G) |
Barbados. Barbados National Drug Formulary (BNDF) | 80.04 Serums | No observations |
Cayman Islands Health Services Authority Pharmacy Drug Formulary | 14.02 Immunoglobulin | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.1. Human immunoglobulins |
Others observations: Indicated for primary immune deficiency and Kawasaki disease. |
PAHO Strategic Fund Medicine List | 4.1. Plasma fractions for specific use |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
Barbados. Barbados National Drug Formulary (BNDF) | 80.04 Serums | No observations |
List | Section | Observation |
---|---|---|
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 14.02. INMUNOGLOBULINAS HUMANAS | No observations |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 23. VACUNAS, TOXOIDES, INMUNOGLOBULINAS, ANTITOXINAS | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.1. Human immunoglobulins |
Others observations: Indicated for primary immune deficiency. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.1. Human immunoglobulins |
Others observations: Indicated for primary immune deficiency. |
Ecuador | Essential Medicines List - Ecuador | No observations |